SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-08-013437
Filing Date
2008-02-27
Accepted
2008-02-27 17:53:36
Documents
2
Period of Report
2008-02-26

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1546
2 EX-24 ex-24.htm EX-24 8464
  Complete submission text file 0001104659-08-013437.txt   11961
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Issuer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address (617) 498-3300
Bonventre Joseph Vincent (Reporting) CIK: 0001428255 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14732 | Film No.: 08647808